How are pediatric doses typically determined?

• A. By body surface area only.
• B. By random dosing.
• C. By using the adult dose without adjustments.
• D. By weight-based dosing and allometric scaling, with maturation factors for organ function.

Answer: (D)

In pediatrics, dosing is guided by size and how a child’s organ systems develop. Start with weight-based dosing because a child’s body size directly influences how much drug distributes and how quickly it is cleared. Beyond simple weight, use allometric scaling to reflect how pharmacokinetic processes don’t rise and fall in a strictly proportional way with weight—clearance and other parameters often scale with weight to a power (modern practice uses this concept to better predict exposure across ages). Add maturation factors to account for the fact that organ function, especially kidney and liver activity, matures with age. Young children, especially neonates and infants, may clear drugs more slowly than older kids or adults, and these maturation changes gradually modify dosing needs.

So the best approach combines weight-based dosing with allometric scaling and incorporates maturation factors for organ function to tailor dosing as kids grow. Using body surface area alone misses size and maturation nuances, random dosing is unsafe, and simply copying adult doses ignores both size and developmental differences.